|
SLC39A9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99347221957669E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10642614462131E-12 |
| Normal-vs-Stage2 |
6.3991001386654E-10 |
| Normal-vs-Stage3 |
1.19020000000081E-06 |
| Normal-vs-Stage4 |
2.383900E-02 |
| Stage1-vs-Stage2 |
3.170000E-01 |
| Stage1-vs-Stage3 |
9.756200E-01 |
| Stage1-vs-Stage4 |
4.683000E-01 |
| Stage2-vs-Stage3 |
4.110200E-01 |
| Stage2-vs-Stage4 |
1.908440E-01 |
| Stage3-vs-Stage4 |
5.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24598117881669E-13 |
| Normal-vs-AfricanAmerican |
2.67360000805184E-09 |
| Normal-vs-Asian |
3.57500000003341E-06 |
| Caucasian-vs-AfricanAmerican |
5.472800E-01 |
| Caucasian-vs-Asian |
5.576400E-01 |
| AfricanAmerican-vs-Asian |
4.634600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72117875507638E-12 |
| Normal-vs-Female |
9.37980004778183E-09 |
| Male-vs-Female |
2.049000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.39629996454005E-09 |
| Normal-vs-Extreme_Weight |
1.83997261871127E-12 |
| Normal-vs-Obese |
1.23400000218155E-08 |
| Normal-vs-Extreme_Obese |
7.021400E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.856000E-01 |
| Normal_Weight-vs-Obese |
6.006800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.902600E-01 |
| Extreme_Weight-vs-Obese |
1.355830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.365800E-01 |
| Obese-vs-Extreme_Obese |
6.010600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.082300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.7489999993312E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
5.76270031693582E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.113400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.677000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.872170E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.958800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.729800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.39321928730396E-12 |
| Normal-VS-Type2 PRCC |
1.6278089987054E-12 |
| Normal-VS-KIRP CIMP |
1.213000E-01 |
| Normal-VS-Unclassified PRCC |
5.09240000168276E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.198100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.416400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.500000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.275930E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.755200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.046570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.99520433297585E-15 |
| Normal-vs-N1 |
2.220300E-03 |
| Normal-vs-N2 |
3.52510000001249E-06 |
| N0-vs-N1 |
9.286500E-02 |
| N0-vs-N2 |
2.840400E-01 |
| N1-vs-N2 |
1.984010E-01 |
|
|
